Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
46<br />
HEALTH<br />
THE NATION TUESDAY, APRIL 28, 2015<br />
Funding research ‘ll promote medicine, say experts<br />
PECIALISTS in medicine<br />
have called for more funding<br />
for research and devel- Sopment to advance medicine in<br />
Nigeria.<br />
According to an embryologist<br />
Prof Oladapo Ashiru, more awareness<br />
and support for medical education<br />
are required to move the<br />
country’s healthcare forward.<br />
Ashiru spoke at the 14 th Annual<br />
Scientific Conference of the Society<br />
of Experimental and Clinical<br />
Anatomists of Nigeria (SECAN),<br />
MALARIA prevention can<br />
save Nigeria billions of<br />
Naira as curing the disease<br />
is more expensive than preventing it.<br />
Efforts have been made by various<br />
groups to prevent the disease. For instance,<br />
the Society for Family Health<br />
(SFH), has encouraged the use of mosquito<br />
nets by distributing same freely<br />
(Long Lasting Insecticidal Nets<br />
freely).<br />
According to Safurat Eromosele of<br />
SFH, “LLINs are factory-treated mosquito<br />
nets that are safe, easy to use,<br />
and come in a variety of sizes and<br />
colours to address individual needs.<br />
Some LLINs are effective for up to four<br />
years and will last a minimum of 20<br />
washes – they require no re-treatment<br />
during this time, making them five<br />
to 10 times more effective than conventional<br />
re-treatable mosquito<br />
nets.LLINs are an inexpensive and<br />
easy way to prevent malaria and thus<br />
reduce its burden on the health and<br />
economic well-being of Nigerians.<br />
SFH uses its extensive marketing and<br />
distribution channels to move LLINs<br />
all across Nigeria so that they are<br />
available to everyone, particularly<br />
women and children.”<br />
She said when prevention fails,<br />
treatment of malaria is critical. “In<br />
seeking treatment for malaria, some<br />
mothers are given the wrong drugs<br />
for their children, while others find<br />
treatment options confusing and difficult<br />
to complete the dosage.<br />
In 2003, SFH and other stakeholders<br />
developed an innovative approach<br />
to “pre-package” malaria<br />
treatment for easy use by mothers and<br />
families to rapidly and correctly treat<br />
malaria. SFH’s treatment<br />
programmes to combat malaria are<br />
focused on promoting and distributing<br />
an innovative and effective drug<br />
for malaria, called Artemisinin-based<br />
Combination Therapy (ACT). This is<br />
an easy way to use pre-packaged drug<br />
combination that ensures effective<br />
By Wale Adepoju<br />
‘Malaria prevention<br />
can save billions’<br />
Lagos. It had as theme: Current<br />
trends in biomedical research; the subtheme<br />
was: the anatomist: catalyst for<br />
medical education.<br />
He said funding research, especially<br />
in anatomy will move<br />
health care forward because<br />
“anatomists serve as a mechanism<br />
for promoting medical education.”<br />
The reproductive expert said<br />
there is need for advances in anatomical<br />
teaching and research to<br />
By Oyeyemi Gbenga-Mustapha<br />
treatment of malaria for children and<br />
adults as well. Now, SFH promotes<br />
ACT treatment using the pre-packaged<br />
method and distributes this product<br />
throughout Nigeria, especially in<br />
remote and rural communities. In<br />
2014 alone, about 8.2 million doses of<br />
ACTs were distributed in the country.<br />
“SFH is actively engaged in<br />
behavioural change communication<br />
activities through mass media and<br />
community-based interpersonal<br />
communication activities to facilitate<br />
the adoption of positive behaviours<br />
by individuals and communities.<br />
These interpersonal communication<br />
activities available mostly in hard to<br />
reach communities, help to ensure<br />
that individuals are equipped with the<br />
right information and attitudes to prevent<br />
and treat malaria. SFH also<br />
works closely with the Federal Ministry<br />
of Health on technical matters,<br />
education, training, and coordinating<br />
on policy and research to move the<br />
nation forward on both prevention<br />
and treatment issues in the battle<br />
against malaria,” she stated.<br />
On other efforts to control the<br />
scourge, she said, “SFH has four<br />
projects that address malaria – the<br />
Global Fund Malaria Project, the Expanded<br />
Social Marketing Project in<br />
Nigeria (ESMPIN), the Rapid Access<br />
Expansion (RAcE) Programme and<br />
the Africa Health Markets for Equity<br />
(AHME) Programme.<br />
ACTwatch collects data to inform<br />
evidence-based malaria control policies<br />
and programmes. Regardless of<br />
the giant strides made so far, more<br />
needs to be done to defeat this fight<br />
against malaria in Nigeria. This could<br />
be achieved by intensifying our efforts<br />
and exploring innovative approaches<br />
to tackle the disease.<br />
Behaviour change communication to<br />
increase use of malaria prevention is<br />
important in this regard.”<br />
First malaria vaccine out soon<br />
HE world’s first malaria<br />
vaccine, made by<br />
TGlaxoSmithKline (GSK.L),<br />
could be approved by international<br />
regulators for use in Africa from<br />
October after final trial data showed<br />
it offered partial protection for up<br />
to four years.<br />
The shot, called RTS,S and designed<br />
for children in Africa, would<br />
be the first licensed human vaccine<br />
against a parasitic disease and could<br />
help prevent millions of cases of<br />
malaria, which currently kills more<br />
than 600,000 people a year.<br />
Experts have long hoped scientists<br />
would be able to develop an effective<br />
malaria vaccine, and researchers<br />
at the British drugmaker GSK<br />
have been working on RTS,S for 30<br />
years.<br />
Hopes that this shot would be the<br />
final answer to wiping out malaria<br />
were dampened when trial data released<br />
in 2011 and 2012 showed it only<br />
reduced episodes of malaria in babies<br />
aged 6-12 weeks by 27 percent, and by<br />
around 46 percent in children aged 5-<br />
17 months.<br />
But the final stage follow-up data<br />
published in the Lancet journal on Friday<br />
showed vaccinated children continued<br />
to be protected four years on,<br />
albeit at a declining rate — an important<br />
factor given the prevalence of the<br />
disease — and rates of protection were<br />
stronger with a booster shot.<br />
“Despite the falling efficacy over<br />
time, there is still a clear benefit from<br />
RTS,S,” said Brian Greenwood, a professor<br />
at the London School of Hygiene<br />
& Tropical Medicine who worked on<br />
the study.<br />
He said an average of 1,363 cases of<br />
clinical malaria were prevented over<br />
four years for every 1,000 children vaccinated,<br />
or 1,774 cases with a booster<br />
shot — the children would normally<br />
be expected to have had several cases<br />
of infection over that period.<br />
In babies, over three years of followup,<br />
an average 558 cases were prevented<br />
for every 1,000 vaccinated; and<br />
983 cases in those who got a booster.<br />
“Given that there were an estimated<br />
198 million malaria cases in<br />
2013, this level of efficacy potentially<br />
translates into millions of<br />
cases of malaria in children being<br />
prevented,” Greenwood said.<br />
• Source: www.Reuters.com<br />
take Nigeria to the next level.<br />
This, he said, would lead to improved<br />
understanding of human<br />
system, and as such ensure longevity<br />
and better treatment outcome.<br />
Professor of Anatomy at the<br />
Lagos University Teaching Hospital<br />
(LUTH), Abayomi<br />
Okanlawon said the Federal Government<br />
needs to provide more<br />
funding for research.<br />
He said the discovery of new<br />
medicine and therapies require<br />
careful scientific experimentation,<br />
development and evaluation.<br />
Okanlawon said research is a<br />
prerequisite for medical advances,<br />
adding: “It ensures that<br />
• From left: Second prize winner, Mrs Oby Ibeh Okpareke; Managing Director, SKG Pharma Ltd, Akpa;<br />
Manager of Jonaco Pharmacy, Mr Chizoba Oleuku; General Manager, Sales and Customer Care, Mrs Patricia<br />
Iloba and MD, Eternity Concepts Ltd, Mr Chidi Akabuogu at the event.<br />
SKG Pharma launches products<br />
PHARMACEUTICAL company<br />
SKG Pharma Limited has<br />
promised continued product<br />
development to meet customers’<br />
yearnings for effective products, its<br />
Managing Director, Okey Akpa,<br />
has said.<br />
Akpa spoke during the SKG’s<br />
Trade Partners Conference and<br />
Awards in Lagos.<br />
According to him, the conference<br />
was to appreciate the trade partners<br />
who have been adding value to the<br />
company by interfacing between<br />
SKG Pharma and the final consumer<br />
of the products.<br />
The company also used the opportunity<br />
to launch some new<br />
products, such as SKG Rexifen,<br />
which is a 400mg, Ibuprofen capsule<br />
By Oyeyemi Gbenga-Mustapha<br />
health services support improved<br />
delivery, access and cost.”<br />
He called for public-private<br />
partnership (PPP) to promote biomedical<br />
research and as such ensure<br />
medical education.<br />
The anatomist advised the government<br />
to set up research centres<br />
across the country to develop the<br />
healthcare industry.<br />
“The Nigerian Universities<br />
Commission (NUC) has been promoting<br />
responsible and qualitative<br />
research to develop medicine,”<br />
he said.<br />
The future, he said, is for biomedical<br />
research to seek fundamental<br />
knowledge about the nature<br />
and behavior of living systems,<br />
adding that the knowledge<br />
will be applied to enhance human<br />
health, lengthen life and prevent<br />
illness and disability.<br />
SECAN President, Prof Hakeem<br />
Fawehinmi said anatomy as a<br />
discipline has faced a crisis of<br />
identity and purpose, adding that<br />
this has raised educational concerns.<br />
He said the approach to teaching<br />
of anatomy and medicine as a<br />
whole is shifting from its traditional<br />
methods to self-directed<br />
problem based or the integrated<br />
system oriented learning. “It is,<br />
therefore, taking advantage of E-<br />
teaching and learning,”<br />
Fawehinmi added.<br />
product, SKG Galways 100mg vitamin<br />
C drops for newborns to 12<br />
years plus, SKG Novadex<br />
Paracetamol 100mg BP drops for<br />
newborns to 11 months old babies<br />
with the advantage of being sugar<br />
free and SKG Novavite<br />
Multivitamin15ml drops for<br />
newborns to 12 months old babies<br />
plus, fortifies babies immune<br />
system against ailments and<br />
infections.<br />
The event was attended by trade<br />
partners all over the country. There<br />
were regional and national awards<br />
to honour high performing trade<br />
partners. These awards were<br />
complemented with mouth-watering<br />
gifts.<br />
The grand award winner, Jonaco<br />
Pharmacy based in Onitsha, through<br />
its Manager Chizoba Oleuku,<br />
thanked SKG Pharma for helping<br />
him grow his business. “SKG looks<br />
out for its distributors and makes<br />
sure they grow along with the<br />
company, no one is left behind and<br />
I intend to remain in the SKG<br />
family” Mr. Oleuku said as he lifted<br />
his golden trophy beaming with<br />
smile.<br />
The second position went to<br />
Simba Pharmaceuticals represented<br />
by Mrs. Oby Ibeh Okpareke while<br />
the third position’s trophy was<br />
lifted by Mr. Chidi Akabougu of<br />
Eternity Concept.<br />
• From right: President, Pharmaceutical Society of Nigeria (PSN), Mr Olumide Akintayo; Vice President, Nigeria<br />
Academy of Pharmacy (NAP), Sir Ifeanyi Atueyi and Representative of Registrar, Pharmacists Council of Nigeria<br />
(PCN), Amaka Okafor, at the Pharmacy Education Summit of Nigeria Academy of Pharmacy (NAP) in Lagos.<br />
PHOTO: ABIODUN WILLIAMS